Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$6.3 - $10.86 $39,803 - $68,613
-6,318 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$9.44 - $12.24 $12,432 - $16,120
-1,317 Reduced 17.25%
6,318 $68,000
Q3 2021

Nov 15, 2021

BUY
$9.63 - $12.47 $73,525 - $95,208
7,635 New
7,635 $92,000

Others Institutions Holding AMYT

About Amryt Pharma plc


  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.